Skip to content

Efficacy And Safety of Pneumatic Trabeculoplasty

Phase 4 Study to Evaluate Efficacy And Safety of Pneumatic Trabeculoplasty (PNT) in Subjects Affected by Primary Open Angle Glaucoma

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01540331
Enrollment
27
Registered
2012-02-28
Start date
2009-06-30
Completion date
2012-01-31
Last updated
2012-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary Open Angle Glaucoma

Brief summary

The purpose of this study is to evaluate prospectively the PNT safety and efficacy in term of IOP reduction in a group of previously or newly diagnosed glaucomatous subjects.

Detailed description

A group of subjects affected by Primary Open Angle Glaucoma (POAG) underwent 3 PNT treatments to evaluate one-year efficacy in term of IOP reduction and one-year safety in term of incidence of adverse events

Interventions

DEVICEmodel 1000 PNT vacuum controller (the vacuum device for ocular suction)

A Pneumatic Trabeculoplasty treatment, composed of 3 single PNT applications at day 0, 7 and 90. Each treatment consist in a ocular pneumatic suction of 500inchHg administered for 60 seconds in perilimbal region through the device (model 1000 PNT vacuum controller). This suction is then repeated after a 5 minutes pause.

Sponsors

University of Catanzaro
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
SINGLE (Caregiver)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Subjects affected by primary open angle glaucoma

Exclusion criteria

* Any local or systemic contraindication to timolol topical therapy * Chronic iritis and/or uveitis in one or both eyes, * History of inflammatory glaucoma, * Hemorrhagic glaucoma, * Post-traumatic glaucoma, * Phacolytic glaucoma, * Acute glaucomatocyclitic attack, * Closed angle/narrow angle glaucoma in one or both eyes, * Previous corneal transplantation, * Proliferative diabetic retinopathy with/without iris neovascularisation, * Significative disk cupping (90% of complete disk area), * Large and severe perimetric defects (I. e. a central perimetric residual not above 10 central degrees), * Dry/wet age related macular degeneration in one or both eyes, * Previous glaucoma surgery (Laser therapy was not considered) * Keratitis * Severe dry eye disease, * Corneal dystrophies * High myopia (more than 6 dioptres) * Peripheral retinal degenerations with risk of retinal detachment

Design outcomes

Primary

MeasureTime frameDescription
intraocular pressure (IOP)Patients will be followed for one year. Time-points:recruitment, Basal (30 days after recruitment), Follow-Up2 (30 days after basal), Follow-Up3 (3 months after basal), Follow-Up4 (6 months after basal), Follow-Up5 (one year after basal)to evaluate one-year intraocular pressure (IOP) reduction after a standard pneumatic trabeculoplasty (PNT) treatment

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026